OP#55 - Trastuzumab co-treatment improves survival of mice with PC-3 prostate cancer xenografts treated with [177Lu]Lu-DOTAGA-PEG2-RM26 GRPR antagonists
| Autor: | Mitran, B., Rinne, S., Vorobyeva, A., Altai, M., Konijnenberg, M., Maina, T., Nock, B., Tolmachev, V., Rosenström, U., Orlova, A. |
|---|---|
| Zdroj: | In Nuclear Medicine and Biology July 2019 72-73 Supplement 1:S21-S22 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect